CIED Implantation in Low BMI Patients

Inclusion Criteria: * BMI of less than 23. * Already scheduled for or a clinical decision made to have one of the following qualifying CIED implant procedures using a device cleared by the U.S. FDA: * De novo pacemaker, ICD, or S-ICD; * Upgrade or change out of existing CIED to a pacemaker, ICD, or S-ICD * Clinically stable and able to tolerate procedure. * Be able and willing to return for follow-up care through the 3-month visit. * Must possess the ability to provide informed consent. Exclusion Criteria: * Patients with a known sensitivity to porcine material. * Participation in another clinical study. * Active infection. Clinical diagnosis of an active infection at the time of CIED implant (CIED infection, pneumonia, UTI, endovascular, cellulitis, bacteremia, or other major systemic infection). * Female patient who is pregnant, or planning to become pregnant during the length of the study. * Prior history of a CIED infection, other prosthetic device infection, or endovascular infection, including endocarditis in the past 12 months. * Life expectancy of less than 3 months.